Previous 10 | Next 10 |
Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600 Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600 PR Newswire NEW YORK , May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs ...
Organogenesis Holdings Inc. (ORGO) Q1 2021 Earnings Conference Call May 10, 2021 5:00 PM ET Company Participants Gary Gillheeney - President and CEO David Francisco - Chief Financial Officer Conference Call Participants Matt Miksic - Credit Suisse Ryan Zimmerman - BTIG Richard Newitter - SVB ...
Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO) Q1 2021 Earnings Call May 10, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis Holdings Inc (ORGO) Q1 2021 Earnings Call Transcri...
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Organogenesis Holdings Inc. (Nasdaq: ORGO), please note that in the third bullet of the First Quarter 2021 Financial Results Summary, the net revenue from the sale of ...
Organogenesis Holdings (ORGO): Q1 GAAP EPS of $0.07 beats by $0.09.Revenue of $102.55M (+66.1% Y/Y) beats by $16.47M.Shares +4.3%.Press Release For further details see: Organogenesis Holdings EPS beats by $0.09, beats on revenue
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, tod...
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, tod...
CANTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, toda...
Healthcare has been lagging the market, but that is now changing. As biotechs consolidate, other healthcare industry groups are powering the sector to a breakout. Medical Devices and Services are poised to benefit from overarching trends and pent-up demand. 3 healthcare stocks...
CANTON, Mass., April 12, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, t...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...